Atlas Trials

An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease

Clinical trial NCT00071877 · COMPLETED

Trial details

NCT number
NCT00071877
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Fabry Disease
Start date
2003-10-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.